Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis ; volume:8 ; number:1 ; day:19 ; month:11 ; year:2018 ; pages:1 ; date:12.2018
Scientific reports ; 8, Heft 1 (19.11.2018), 1, 12.2018
- Klassifikation
-
Allgemeines, Wissenschaft
- Urheber
-
Passiglia, Francesco
Rizzo, Sergio
Di Maio, Massimo
Galvano, Antonio
Badalamenti, Giuseppe
Listì, Angela
Gulotta, Leonardo
Castiglia, Marta
Fulfaro, Fabio
Bazan, Viviana
Russo, Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35524-y
- URN
-
urn:nbn:de:101:1-2019010101553155967665
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Passiglia, Francesco
- Rizzo, Sergio
- Di Maio, Massimo
- Galvano, Antonio
- Badalamenti, Giuseppe
- Listì, Angela
- Gulotta, Leonardo
- Castiglia, Marta
- Fulfaro, Fabio
- Bazan, Viviana
- Russo, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
EGFR exon 20 insertion mutations in NSCLC
Sulforaphane attenuates EGFR signaling in NSCLC cells
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation
Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
EGFR exon 20 insertion mutations in NSCLC
Sulforaphane attenuates EGFR signaling in NSCLC cells
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation
Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
EGFR exon 20 insertion mutations in NSCLC
Sulforaphane attenuates EGFR signaling in NSCLC cells
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation
Osimertinib : Therapieplanung und Therapiesequenzen beim fortgeschrittenen EGFR-mutierten NSCLC
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations